Skip to main content

Cardiac Autonomic Neuropathy Screening

Meaning

Cardiac Autonomic Neuropathy Screening is a clinical assessment protocol designed to detect damage or dysfunction in the autonomic nerves specifically controlling heart rate and blood pressure regulation. This screening is crucial for identifying early subclinical changes, particularly in individuals with chronic metabolic conditions such as diabetes or significant hormonal imbalances. The presence of Cardiac Autonomic Neuropathy (CAN) signals a profound disruption in the neurovisceral axis, elevating the risk for cardiovascular events and all-cause mortality. Early detection allows for targeted interventions to mitigate disease progression and improve overall physiological resilience.